back to company universe
AI infrastructure

Biolinco

Biolinco develops an AI-enabled, high-throughput cell line screening platform for biopharmaceutical manufacturers to efficiently identify optimal cell lines using DNA barcoding technology, addressing the issue of low-yielding cell lines

sources
1
Evidence entries preserved.
affiliations
1
Techstars
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Techstars

techstars-portfolio #1591

Biolinco develops an AI-enabled, high-throughput cell line screening platform for biopharmaceutical manufacturers to efficiently identify optimal cell lines using DNA barcoding technology, addressing the issue of low-yielding cell lines

source
generated read
High Signal interpretation

Biolinco is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
DNA barcoding technologybiopharmaceutical manufacturershigh-throughput cell line screening platformAI-enabled
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to Biolinco

AI infrastructure · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

64x Bio

match 85

The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating

shared extracted concept terms: screen, high, cell, line; shared product terms: screen, high, yield, cell; shared product theme: context and memory

Nephrogen

match 71

Nephrogen is a Stanford biotech spin-out developing curative genetic medicines for kidney and pancreatic diseases. Kidney disease alone affects 1 in 7 Americans, and neither indication has any approved gene-based therapies. Nephrogen's underlying platform combines AI and high-throughput screening to engineer safer, more efficient, and less expensive gene delivery vehicles for reaching the kidney and pancreas, and has attracted non-dilutive funding from seven major pharmaceutical companies includ

shared extracted concept terms: high, throughput, screen; shared product terms: develop, high, throughput, screen; shared product theme: context and memory; same category: AI infrastructure; shared affiliation: Techstars

Pando Bioscience

match 70

Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.

shared extracted concept terms: high, throughput, screen; shared product terms: high, throughput, screen, efficiently; shared product theme: context and memory; same category: AI infrastructure

1910

match 54

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

shared extracted concept terms: high, throughput, enabl; shared product terms: high, throughput, enabl

Blink Identity

match 45

High-throughput, low-friction biometric face and iris identification for security, access control & VIP experiences.

shared extracted concept terms: high, throughput; shared product terms: high, throughput, low; shared affiliation: Techstars

GRIND Interactive

match 25

GRIND has developed the first portable rebounding machine enabling optimal daily repetition to reach peak performance.

shared product terms: develop, enabl, optimal; shared affiliation: Techstars